United Therapeutics (UTHR) Tops Q3 EPS by 120c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $499.73 --0%
Financial Fact:
Income from continuing operations before income taxes: 239.1M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Income from continuing operations before income taxes: 239.1M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.55, $1.20 better than the analyst estimate of $2.35. Revenue for the quarter came in at $386.2 million versus the consensus estimate of $363.5 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- Laser Photonics Corporation (LASE) Reports Q2 Loss of $0.08
- The LGL Group (LGL) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
